financial guidance

Sophia Genetics Lowers 2022 Revenue Guidance, Posts 15 Percent Q2 Sales Growth

QuidelOrtho Q2 Revenues Rise 34 Percent

CareDx Q2 Revenues Grow 9 Percent but Miss Estimates as Firm Lowers Full-Year Guidance 

Natera Q2 Revenues Rise 40 Percent on Higher Test Volume

Siemens Healthineers Q3 Revenues Drops With COVID-19 Testing

MDxHealth Acquires Prostate Cancer Testing Business From Exact Sciences for up to $100M

Qiagen Reports Strong Non-COVID Sales Growth in Q2; Raises Full-Year Guidance

Invitae to Lay Off Over 1,000 Workers Amid Restructuring, Leadership Transition

Quotient Limited Fiscal Q4 Revenues Up 2 Percent

Agilent Technologies Fiscal Q2 Revenues Rise 5 Percent

Sema4 Q1 Revenues Decline 16 Percent

Exagen Q1 Revenues Drop 2 Percent

Cue Health Q1 Revenues Rise 178 Percent on Product Sales

Castle Biosciences Q1 Revenues Grow 18 Percent

DiaSorin Q1 Revenues Rise 34 Percent Despite Dip in COVID-19 Test Demand

Meridian Bioscience Fiscal Q2 Revenues Climb 30 Percent

Adaptive Biotechnologies Q1 Revenues Rise Slightly in Q1